Barbara Leuchs
14Patents
2h-index
30Co-inventors
50Inventor score
Filing activity: Dec 1, 2010 → Dec 6, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8828400B2 | Antibody that binds to H-1 parvovirus | Physics | 4 | Active |
| US10624935B2 | Parvovirus formulation for treating tumors | Human Necessities | 2 | Active |
| US9700588B2 | Use of parvovirus for eliminating cancer stem cells (CSCs) | Chemistry; Metallurgy | 2 | Active |
| US9333225B2 | Oncolytic virotherapy for the therapy of ewing'S sarcoma | Chemistry; Metallurgy | 2 | Active |
| US10266810B2 | Method for large scale production and purification of parvovirus | Chemistry; Metallurgy | 1 | Active |
| US11193112B2 | Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particles | Chemistry; Metallurgy | 1 | Active |
| US9803219B2 | Adenovirus derived helper virus for enhancing recombinant parvovirus production | Chemistry; Metallurgy | 1 | Active |
| US12404498B2 | Optimized parvovirus H-1 production | Chemistry; Metallurgy | 0 | Active |
| US10525091B2 | Use of parvovirus for eliminating cancer stem cells (CSCs) | Chemistry; Metallurgy | 0 | Active |
| US9234183B2 | Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid | Chemistry; Metallurgy | 0 | Active |
| US11324788B2 | Parvovirus formulation for treating tumors | Human Necessities | 0 | Active |
| US10227609B2 | Modified parvovirus useful for gene silencing | Chemistry; Metallurgy | 0 | Active |
| US11964015B2 | Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor | Chemistry; Metallurgy | 0 | Active |
| US11027013B2 | Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.